Copyright © 2026 Temenos Copyright © 2026 Temenos 1 Disclaimer Our presentation and this document may contain forward-looking statements relating to the future of the business and financial performance of Temenos AG. Any statements we make about our expectations, plans and prospects for the Company, including any guidance on the Company's financial performance, constitute forward-looking statements. The forward-looking financial information provided by the Company on the conference call and in this document ...

INVESTOR DAY FEBRUARY 25, 2026 POSITIONED TO ACCELERATE GROWTH 2 FORWARD-LOOKING STATEMENTS – DISCLAIMER This presentation contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include all statements that are not historical statements of fact and those regarding the Company's intent, belief, or expectations, including statements with respect to our 2026 financial guidance and 2028 targets. Words such as "anticipate(s)," "expect(s)," "intend(s)," "b ...

Valens Semiconductor (NYSE:VLN) February 2026 Adjusted EBITDA is defined as net profit (loss) before financial income (expense), net, income taxes, equity in earnings of investee, depreciation and amortization, further adjusted to exclude share-based compensation, certain batch production incident expenses and change in the fair value of the Forfeiture Shares and earnout liability, which may vary from period-to-period. We caution investors that amounts presented in accordance with our definition of Adjusted ...

Brett Monia, Ph.D. Chief Executive Officer Holly Kordasiewicz, Ph.D. Chief Development Officer YE:2025 Business Update and Financial Results February 25, 2026 Nasdaq: IONS 1 On Today's Earnings Call Beth Hougen Chief Financial Officer Eugene Schneider, M.D. Chief Clinical Development Officer 2 Eric Swayze, Ph.D. Executive Vice President, Research Forward-Looking Statements This presentation includes forward-looking statements regarding our business, financial guidance and the therapeutic and commercial pote ...

Ironwood Pharmaceuticals Q4 and FY 2025 Investor Update February 25, 2026 1 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about our ability to execute on our mission; our strategy, business, financial position and operations; our ability to drive growth and profitability; the commercial potentia ...

ARCHROCK, INC. Fourth Quarter and Full Year 2025 Earnings Supplement February 2026 Forward-Looking Statements All statements in this presentation (and oral statements made regarding the subjects of this presentation) other than historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of uncertainties and factors tha ...

INVESTOR PRESENTATION Q4 FY25 Disclaimer Forward-Looking Statements This presentation contains forward-looking statements, including, among other things, statements regarding our future financial performance and our strategies and business initiatives. Words such as "may," "should," "will," "believe," "expect," "anticipate," "target," "project," and similar phrases that denote future expectation or intent regarding our financial results, operations, and other matters are intended to identify forward-looking ...

Fourth Quarter & Full-Year 2025 F e b r u a r y 2 5 , 2 0 2 6 FORWARD-LOOKING STATEMENTS This presentation contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. Examples of such forward-looking statements include but are not limited to: (i) statements regarding the Company's results of operations and financial condition; (ii) statements of plans, objectives or goals of the ...

1 © 2025 Lumen Technologies. All Rights Reserved. Jim Breen SVP Investor Relations 2 Forward Looking Statement Except for historical and factual information, the matters set forth in this presentation and other of our oral or written statements identified by words such as "estimates," "expects," "anticipates," "believes," "plans," "intends," "will," and similar expressions with respect to the future are forward-looking statements as defined by the federal securities laws, and are subject to the "safe harbor ...

Management Presentation FEBRUARY 24, 2026 Tanger Outlets Phoenix Table of Contents Our Company and Strategy 3 Activating Growth Leasing, Marketing, and Operations Accelerating Growth A Portfolio Positioned in the Path of Demand External Growth Accretive Portfolio Expansion to Drive Value Appendix 45 4Q 2025 | 2 17 27 35 Our Company and Strategy Tanger Outlets Grand Rapids 3 4Q 2025 | Innovating Retail for 40+ Years | 1981 | 1993 | 16M+ SF | 41 | | --- | --- | --- | --- | | Founded | Listed (NYSE: SKT) | of ...